Mono Pharmacare Ltd
Incorporated in 1994, Mono Pharmacare Limited is engaged in the business of marketing and distribution of pharmaceutical products[1]
- Market Cap ₹ 61.6 Cr.
- Current Price ₹ 34.8
- High / Low ₹ 75.0 / 31.8
- Stock P/E 21.4
- Book Value ₹ 17.2
- Dividend Yield 0.00 %
- ROCE 10.3 %
- ROE 11.8 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 195 to 94.2 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|
| 27 | 122 | 143 | |
| 25 | 116 | 136 | |
| Operating Profit | 2 | 6 | 7 |
| OPM % | 6% | 5% | 5% |
| 0 | 0 | 0 | |
| Interest | 1 | 3 | 3 |
| Depreciation | 0 | 0 | 0 |
| Profit before tax | 1 | 3 | 4 |
| Tax % | 25% | 24% | |
| 1 | 2 | 3 | |
| EPS in Rs | 0.57 | 1.38 | 1.63 |
| Dividend Payout % | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 41% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -21% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|
| Equity Capital | 12 | 18 | 18 |
| Reserves | 1 | 10 | 13 |
| 40 | 41 | 49 | |
| 9 | 12 | 20 | |
| Total Liabilities | 63 | 81 | 100 |
| 1 | 1 | 1 | |
| CWIP | 0 | 0 | 0 |
| Investments | 1 | 0 | 0 |
| 61 | 80 | 99 | |
| Total Assets | 63 | 81 | 100 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | |
|---|---|---|
| -28 | -9 | |
| -1 | 0 | |
| 30 | 8 | |
| Net Cash Flow | 0 | -0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | |
|---|---|---|
| Debtor Days | 296 | 94 |
| Inventory Days | 497 | 139 |
| Days Payable | 103 | 32 |
| Cash Conversion Cycle | 689 | 202 |
| Working Capital Days | 703 | 204 |
| ROCE % | 10% |
Documents
Announcements
-
Updates
22 November 2024 - Mono Pharmacare Limited has informed regarding 'Reciept of Consent letter and Brief profile of Ms. Drashti Rohit Chande for appointment as Additional Independent Director of …
-
Outcome of Board Meeting
14 November 2024 - Mono Pharmacare Limited has informed regarding Board meeting held on November 14, 2024.
-
Financial Result Updates
14 November 2024 - Mono Pharmacare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024.
-
Board Meeting Intimation
6 November 2024 - MONO PHARMACARE LIMITED has informed about Board Meeting to be held on 14-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results of the …
-
Updates
21 October 2024 - Mono Pharmacare Limited has informed regarding 'Non applicability of Corporate Governance for the Quarter ended September 30, 2024'.
Business segment
A) Marketing of Pharmaceutical Products[1]
Co. outsources manufacturing of most of its products and has 19 third-party manufacturers and sells all these products under its own Brand name - “DLS Export”.
Product Portfolio[1] Health Care products, Antibiotic medicines, Cough Cold Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic and antipyretic medicines, Antacid and antiemetics medicines, Cardiac - Diabetic medicines, and cosmocare products.